Xylometazoline Hydrochloride + Dexpanthenol
This medicine should always be used exactly as described in this package leaflet or as directed by your doctor or pharmacist.
Septanazal for Adults nasal spray contains the active substances: xylometazoline hydrochloride and dexpanthenol.
Xylometazoline hydrochloride has a vasoconstrictive effect on the nasal mucosa, reducing swelling of the nasal mucosa and the amount of discharge. This helps to relieve the feeling of a blocked nose. Dexpanthenol is a derivative of pantothenic acid (vitamin B5) with wound-healing and protective properties for the nasal mucosa.
Septanazal for Adults is indicated:
Septanazal for Adults is intended for adults, adolescents, and children aged 6 years and older.
Before using Septanazal for Adults, discuss with your doctor or pharmacist:
Due to the risk of atrophy of the nasal mucosa, this medicine should only be used in the case of chronic rhinitis under medical supervision.
In case of improper use or excessive use of the spray, the medicine may cause systemic side effects, especially in children (see section 4).
Long-term use of the medicine or use of the medicine in higher doses than recommended may lead to chronic swelling and sometimes thinning (damage) of the nasal mucosa.
You should not use Septanazal for Adults while using:
Avoid direct contact of the medicine with the eyes.
Do not exceed the dose recommended by your doctor. Consult your doctor regarding the duration of treatment and frequency of use in children.
Septanazal for Adults is intended for use in adolescents and children aged 6 years and older. For children under 6 years of age, Septanazal for Children, a nasal spray containing a lower dose of active substances, is available.
The use of this medicine in children under 12 years of age should be supervised.
If the child's symptoms worsen or do not improve after 3 days of treatment, consult your doctor.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Avoid concomitant use of Septanazal for Adults with medicines used to lower blood pressure (e.g., methyldopa) due to the possible effect of xylometazoline on blood pressure.
Concomitant use of Septanazal for Adults with certain antidepressants (monoamine oxidase inhibitors or tricyclic antidepressants) and medicines that increase blood pressure may cause an increase in blood pressure.
Concomitant use of Septanazal for Adults with influenza treatments and cough and cold medicines containing sympathomimetics (e.g., pseudoephedrine, ephedrine, phenylephrine, oxymetazoline, xylometazoline, tramazoline, naphazoline, tuaminoheptane) may lead to increased side effects from the cardiovascular and central nervous systems.
Before using Septanazal for Adults, consult your doctor if you are taking any of the above-mentioned medicines.
The medicine can be used independently of meals.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
This medicine should not be used during pregnancy due to the lack of data on safety in pregnant women.
This medicine should not be used during breastfeeding, as it is not known whether xylometazoline hydrochloride passes into breast milk.
It is not expected that this medicine will affect your ability to drive or use machines if used as directed.
This medicine contains less than 1 mmol (23 mg) of sodium per dose, which means it is essentially 'sodium-free'.
This medicine should always be used exactly as described in the package leaflet or as directed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
The recommended dose for adults, adolescents, and children aged 6 years and older is one dose of nasal spray into each nostril up to three times a day, as needed. The dosage depends on the individual patient's sensitivity and clinical response.
Do not use this medicine for more than 7 days. Repeated use is possible only after a few days' break.
The duration of use in children should always be discussed with your doctor.
Remove the protective cap from the spray nozzle.
Before first use or if the spray has not been used for a longer period, press the pump several times until a uniform mist appears.
Place the nozzle into the nostril in an upright position, if possible, and press the pump once. During dosing, gently inhale through the nose. If necessary, repeat in the other nostril.
After each use, wipe the nozzle with a tissue and replace the protective cap.
Patient with increased intraocular pressure (glaucoma), especially with narrow-angle glaucoma, should consult their doctor before using this medicine.
In case of using a higher dose of the medicine than recommended or accidental ingestion of large amounts of the medicine, the following side effects may occur: constriction of the pupils, dilation of the pupils, fever, sweating, paleness of the skin, blue discoloration of the lips (cyanosis), nausea, seizures, cardiovascular disorders (increased heart rate, decreased heart rate, arrhythmias, heart failure, cardiac arrest, high blood pressure [hypertension]), respiratory disorders (pulmonary edema, respiratory disorders), and mental disorders.
It may also cause drowsiness, decreased body temperature, slowed heart rate, and decreased blood pressure, respiratory arrest, and coma.
If any of these symptoms occur, seek medical attention immediately.
Do not use a double dose to make up for a missed dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Uncommon: may affect up to 1 in 100 people:
Rare: may affect up to 1 in 1,000 people:
Very rare: may affect up to 1 in 10,000 people:
Frequency not known (cannot be estimated from the available data):
If you experience any side effects, including any not listed in the package leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the month.
There are no special precautions for storage.
The shelf life of the medicine after first opening the package is 12 months.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The nasal spray solution is a clear, colorless solution.
Septanazal for Adults is supplied in an HDPE container with a spray pump and a transparent protective cap, in a cardboard box. 10 ml of solution is sufficient for 90 doses.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
In order to obtain more detailed information, please contact your local representative of the marketing authorization holder: Krka - Polska Sp. z o.o., ul. Równoległa 5, 02-235 Warsaw, phone: +48 22 573 75 00
Czech Republic | Septanazal pro dospělé |
Bulgaria | Септаназал за възрастни (Septanazal for adults) |
Estonia | Septanazal |
Hungary | Septanazal 1 mg/1 ml + 50 mg/1 ml oldatos orrspray felnőtteknek |
Lithuania | Septanazal 1 mg/50 mg/ml nosies purškalas (tirpalas), suaugusiesiem |
Latvia | Septanazal 1 mg/50 mg/ml deguna aerosols, šķīdums pieaugušajiem |
Poland | Septanazal dla dorosłych |
Romania | Septanazal |
Slovakia | Septanazal sprej pre dospelých |
Slovenia | Septanazal za odrasle |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.